The indications for use for the Imageless Knee Module for the StealthStation® System are identical to the StealthStation® System indications for use. The indications for use are as follows:

The StealthStation® System is intended as an aid for precisely locating anatomical structures in either open or percutaneous procedures. The StealthStation® System is indicated for any medical condition in which the use of stereotactic surgery may be appropriate, and where reference to a rigid anatomical structure, such as the skull, a long bone, or vertebra, can be identified relative to a CT or MR based model or fluoroscopy images of the anatomy.

Example procedures include, but are not limited to:

Cranial Procedures: Cranial Biopsies Tumor Resections Craniotomies/ Craniectomies Skull Base procedures Thalamotomies/Pallidotomies Pituitary Tumor Removal CSF Leak Repair Pediatric Catheter Shunt Placement General Catheter Shunt Placement

ENT Procedures: Transphenoidal Procedures Intranasal Procedures Orbital Nerve Decompression Procedures Optic Nerve Decompression Procedures Polyposis Procedures Endoscopic Dacryocystorhinostomy Encephalocele Procedures

Spinal Procedures: Spinal Implant Procedures, such as Pedicle Screw Placement

Orthopedic Procedures:

Total Knee Arthroplasty (Primary and Revision) Unicompartmental Knee Arthroplasty Minimally Invasive Orthopedic Procedures Total Hip Replacement (Primary and Revision) Tumor Resection and Bone/Joint Reconstruction Femoral Revision Placement of Hiosacral Screws Stabilization and Repair of Pelvic Fractures (Including but not Limited to Acetabular Fractures)

Sinus procedures, such as Maxillary Antrostomies, Ethmoidectomies, Sphenoidotomies/Sphenoid Explorations, Turbinate Resections, and Frontal Sinusotomies

Device Description

This submission describes updates made to the StealthStation® System to include software algorithms that enable the establishment of stereotactic coordinates without the use of preoperative or intra-operative image datasets.

AI/ML Overview

This document is a 510(k) premarket notification for a device modification, specifically the "Imageless Knee Module for the StealthStation® System." The document does not contain the acceptance criteria or a study that proves the device meets specific performance criteria in the way a clinical trial or performance study would.

Instead, the submission focuses on demonstrating substantial equivalence to previously cleared predicate devices. The listed sections primarily cover:

Manufacturing and Contact Information
Product Name and Classification
Date Summary Submitted
Description of Device Modification: The key change is software algorithms to establish stereotactic coordinates without preoperative or intra-operative image datasets, which was previously required for the predicate device.
Substantial Equivalence: This section explicitly states, "The Imageless Knee Module for the StealthStation® System was shown to be substantially equivalent to the StealthStation System cleared in previous 510(k)'s. As required by risk analysis, all verification and validation activities were performed by designated individual(s) and the results demonstrated substantial equivalence." This means the manufacturer believes the new software does not raise new questions of safety or effectiveness compared to the predicate.
Indications for Use: These are identical to the predicate device.

Therefore, based on the provided text, I cannot extract the requested information regarding acceptance criteria, reported device performance, sample sizes, ground truth, expert qualifications, or MRMC studies. The document is a regulatory submission for substantial equivalence, not a detailed performance study report.

If you are looking for this type of information, it would typically be found in a separate performance study report or verification and validation documentation, which is generally not included in the public 510(k) summary provided by the FDA.

Summary

{0}------------------------------------------------

K0305-52

Summary of Safety and Effectiveness Imageless Knee Module for the StealthStation® System

I. Manufacture:

Medtronic Surgical Navigation Technologies 826 Coal Creek Circle Louisville, CO 80027 USA Telephone Number: (720) 890-3200 Fax Number: (720) 890-3500

MAR 1 9 2003

II. Contact:

Victoria G. Rendon Clinical and Regulatory Affairs Associate Medtronic Surgical Navigation Technologies

Product Name/ Classification Name: III.

Product Name: Imageless Knee Module for the StealthStation® System Classification Name: Stereotaxic Instrument (21 CFR 882.4560) Classification Panel: 84 HAW

Date Summary Submitted IV.

February 19, 2003

V. Description of Device Modification:

VI. Substantial Equivalence:

The Imageless Knee Module for the StealthStation® System was shown to be substantially equivalent to the StealthStation System cleared in previous 510(k)'s. As required by risk analysis, all verification and validation activities were performed by designated individual(s) and the results demonstrated substantial equivalence.

{1}------------------------------------------------

K030552

VII. Indications For Use:

The indications for use for the Imageless Knee Module for the StealthStation® System are identical to the StealthStation® System indications for use. The indications for use are as follows:

Example procedures include, but are not limited to:

Cranial Procedures:	Spinal Procedures:	Orthopedic Procedures:
Cranial Biopsies	Spinal Implant Procedures, such as Pedicle	Total Knee Arthroplasty (Primary and Revision)
Tumor Resections	Screw Placement	Unicompartmental Knee Arthroplasty
Craniotomies/ Craniectomies		Minimally Invasive Orthopedic Procedures
Skull Base procedures		Total Hip Replacement (Primary and Revision)
Thalamotomies/Pallidotomies		Tumor Resection and Bone/Joint Reconstruction
Pituitary Tumor Removal		Femoral Revision
CSF Leak Repair		Placement of Iliosacral Screws
Pediatric Catheter Shunt Placement		Stabilization and Repair of Pelvic Fractures
General Catheter Shunt Placement		(Including but not Limited to AcetabularFractures)
ENT Procedures:
Transphenoidal Procedures
Intranasal Procedures
Orbital Nerve Decompression Procedures

Orbital Nerve Decompression Procedures Optic Nerve Decompression Procedures Polyposis Procedures Endoscopic Dacryocystorhinostomy Encephalocele Procedures Sinus procedures, such as Maxillary Antrostomies, Sphenoidotomies/Sphenoidotomies/Sphenoid

Explorations, Turbinate Resections, and Frontal Sinusotomies

{2}------------------------------------------------

Image /page/2/Picture/1 description: The image is a black and white seal for the Department of Health & Human Services - USA. The seal features a stylized caduceus symbol, which is a staff with two snakes entwined around it. The caduceus is positioned to the right of the text, which is arranged in a circular pattern around the seal. The text reads "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA".

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

MAR 1 9 2003

Ms. Victoria G. Rendon Clinical and Regulatory Affairs Medtronic Surgical Navigation Technologies 826 Coal Creek Circle Louisville, Colorado 80027

Re: K030552

Trade/Device Name: Imageless Knee Module for the StealthStation® System Regulation Number: 21 CFR 882.4560 Regulation Name: Stereotaxic instrument Regulatory Class: II Product Code: HAW Dated: February 19, 2003 Received: February 21, 2003

Dear Ms. Rendon:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration. Iisting of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

{3}------------------------------------------------

Page 2 - Ms. Victoria G. Rendon

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4659. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97) you may obtain. Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers. International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html

Sincerely vours.

Mark H. Milkenon

Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{4}------------------------------------------------

Page 1 of of l

510(k) Number (if known):

Device Name: Imageless Knee Module for the StealthStation® System

Indications for Use:

The indications for use for the StealthStation® System Imageless Knee Software Module is identical to the StealthStation® System indications for use. The indications for use are as follows:

Example procedures include, but are not limited to:

Spinal Procedures: Spinal Implant Procedures, such as Pedicle Screw Placement

Ko30552

Orthopedic Procedures:

Sinus procedures, such as Maxillary Antrostomies, Ethmoidectomies, Sphenoidotomies/Sphenoid Explorations, Turbinate Resections, and Frontal Sinusotomies

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office Of Device Evaluation (ODE)

Prescription Use(Per 21 CFR 801.109)	OR(Optional Format 1-2006)
------------------------------------------	--------------------------------

	Over-The-Counter Use(Division of n-Off)
	Division of General, Restorativeand Neurological Devices

§10(k) Number	K0 3055206469
---------------	-------------------

Regulation Number and Section

§ 882.4560 Stereotaxic instrument.

(a)
Identification. A stereotaxic instrument is a device consisting of a rigid frame with a calibrated guide mechanism for precisely positioning probes or other devices within a patient's brain, spinal cord, or other part of the nervous system.(b)
Classification. Class II (performance standards).